228 related articles for article (PubMed ID: 13129392)
1. Synthesis and physicochemical characterization of folate-cyclodextrin bioconjugate for active drug delivery.
Caliceti P; Salmaso S; Semenzato A; Carofiglio T; Fornasier R; Fermeglia M; Ferrone M; Pricl S
Bioconjug Chem; 2003; 14(5):899-908. PubMed ID: 13129392
[TBL] [Abstract][Full Text] [Related]
2. Specific antitumor targetable beta-cyclodextrin-poly(ethylene glycol)-folic acid drug delivery bioconjugate.
Salmaso S; Semenzato A; Caliceti P; Hoebeke J; Sonvico F; Dubernet C; Couvreur P
Bioconjug Chem; 2004; 15(5):997-1004. PubMed ID: 15366952
[TBL] [Abstract][Full Text] [Related]
3. New cyclodextrin bioconjugates for active tumour targeting.
Salmaso S; Bersani S; Semenzato A; Caliceti P
J Drug Target; 2007 Jul; 15(6):379-90. PubMed ID: 17613656
[TBL] [Abstract][Full Text] [Related]
4. Folate-conjugated β-cyclodextrin from click chemistry strategy and for tumor-targeted drug delivery.
Zhang H; Cai Z; Sun Y; Yu F; Chen Y; Sun B
J Biomed Mater Res A; 2012 Sep; 100(9):2441-9. PubMed ID: 22566147
[TBL] [Abstract][Full Text] [Related]
5. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
[TBL] [Abstract][Full Text] [Related]
6. Cyclodextrin/PEG based hydrogels for multi-drug delivery.
Salmaso S; Semenzato A; Bersani S; Matricardi P; Rossi F; Caliceti P
Int J Pharm; 2007 Dec; 345(1-2):42-50. PubMed ID: 17597313
[TBL] [Abstract][Full Text] [Related]
7. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.
Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P
Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555
[TBL] [Abstract][Full Text] [Related]
8. Structural elucidation of specific noncovalent association of folic acid with native cyclodextrins using an ion mobility mass spectrometry and theoretical approach.
Zimnicka M; Troć A; Ceborska M; Jakubczak M; Koliński M; Danikiewicz W
Anal Chem; 2014 May; 86(9):4249-55. PubMed ID: 24712714
[TBL] [Abstract][Full Text] [Related]
9. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies.
Gabizon A; Horowitz AT; Goren D; Tzemach D; Mandelbaum-Shavit F; Qazen MM; Zalipsky S
Bioconjug Chem; 1999; 10(2):289-98. PubMed ID: 10077479
[TBL] [Abstract][Full Text] [Related]
10. Active Drug Targeting of a Folate-Based Cyclodextrin-Doxorubicin Conjugate and the Cytotoxic Effect on Drug-Resistant Mammary Tumor Cells In Vitro.
Mizusako H; Tagami T; Hattori K; Ozeki T
J Pharm Sci; 2015 Sep; 104(9):2934-40. PubMed ID: 25940848
[TBL] [Abstract][Full Text] [Related]
11. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
12. Folate appended cyclodextrins for drug, DNA, and siRNA delivery.
Ceborska M
Eur J Pharm Biopharm; 2017 Nov; 120():133-145. PubMed ID: 28893691
[TBL] [Abstract][Full Text] [Related]
13. Aqueous solubilization of fullerenes using poly(amidoamine) dendrimers bearing cyclodextrin and poly(ethylene glycol).
Kojima C; Toi Y; Harada A; Kono K
Bioconjug Chem; 2008 Nov; 19(11):2280-4. PubMed ID: 18844391
[TBL] [Abstract][Full Text] [Related]
14. The synthesis of a multiblock osteotropic polyrotaxane by copper(I)-catalyzed huisgen 1,3-dipolar cycloaddition.
Hein CD; Liu XM; Chen F; Cullen DM; Wang D
Macromol Biosci; 2010 Dec; 10(12):1544-56. PubMed ID: 20954201
[TBL] [Abstract][Full Text] [Related]
15. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
[TBL] [Abstract][Full Text] [Related]
16. Comparative study on the inclusion behaviour of cyclodextrin derivatives with venoruton and rutin by thin layer chromatography.
Guo X; Shuang S; Wang X; Dong C; Pan J; Aboul-Enein HY
Biomed Chromatogr; 2004 Oct; 18(8):559-63. PubMed ID: 15386516
[TBL] [Abstract][Full Text] [Related]
17. Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles.
Heidari Majd M; Asgari D; Barar J; Valizadeh H; Kafil V; Coukos G; Omidi Y
J Drug Target; 2013 May; 21(4):328-40. PubMed ID: 23293842
[TBL] [Abstract][Full Text] [Related]
18. A "Ship-in-a-Bottle" strategy to create folic acid nanoclusters inside the nanocages of γ-cyclodextrin metal-organic frameworks.
Xu J; Wu L; Guo T; Zhang G; Wang C; Li H; Li X; Singh V; Chen W; Gref R; Zhang J
Int J Pharm; 2019 Feb; 556():89-96. PubMed ID: 30528633
[TBL] [Abstract][Full Text] [Related]
19. Folate-decorated PEG-PLGA nanoparticles with silica shells for capecitabine controlled and targeted delivery.
Wei K; Peng X; Zou F
Int J Pharm; 2014 Apr; 464(1-2):225-33. PubMed ID: 24463073
[TBL] [Abstract][Full Text] [Related]
20. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
